NREF

NREF looks statistically cheap — a 5.5x P/E on FY2025 diluted EPS of $2.85 and a price of $15.73 sitting roughly 24% below stated book (equity $388M / 18.7M shares ≈ $20.75, though that equity line includes noncontrolling interest). But the headline P/E is a trap. This is an externally managed mortgage REIT whose earnings are dominated by non-cash fair-value swings: the MD&A itself lists 'change in net assets related to consolidated CMBS variable interest entities,' 'change in unrealized gain (loss) on CMBS structured pass-through certificates,' MSCR notes, common-stock investments and MBS as core income components. That is exactly why net income lurched $14.2M → $18.7M → $36.0M → $123M over 2022–2025; the +242% jump reflects marks turning favorable, not a durable earnings base. Capitalize a mark and you overpay for it when it reverses.

The balance sheet is thin and highly levered (liabilities/equity 11.57x, equity just $388M against $4.49B liabilities and only $31.1M cash), which is normal for the model but leaves little cushion against a CRE/CMBS credit shock or rate move. Encouragingly, the company is deleveraging — liabilities −7.3%, long-term debt −3.5%, equity +15.3% — and cash rose sharply off a tiny base. Distribution coverage is the nagging question: FY2025 dividends paid ($35.3M) exceeded operating cash flow ($22.9M, itself down 21.7%). Mortgage REITs fund payouts partly from principal collections that bypass operating cash flow, and NREF pays on its own EAD metric which I'm not given, so I can't confirm a shortfall — but I also can't confirm the ~12% implied yield is covered, and retained earnings remain negative (−$16.5M).